TrialPediatric nephrology (Berlin, Germany)2015

Positive role of rituximab in switching from cyclosporine to mycophenolate mofetil for children with high-dose steroid-dependent nephrotic syndrome.

Shuichiro Fujinaga et al.PubMed ↗Publisher ↗

No numbers read from the abstract.